The adrenergic antagonist improved near vision in adults with presbyopia, with over 20 hours of improvement from a single ...
Atia Vision Announces Durable 36-Month Results from First-in-Human Study of their Dynamic Shape-Changing OmniVu Intraocular Lens System ...
When users rhapsodize about Opus 4.7, in early trials, they often reference a dramatic enhancement of its computer vision, ...
A new clinical study published in the journal of Contact Lens and Anterior Eye showed that patients with astigmatism of at ...
You must wear glasses or contact lenses every time you drive, if you need them ...
New SOL-1 post-hoc analyses presented at VBS reinforce AXPAXLI's unmatched durability in wet AMD with sustained disease control AXPAXLI demonstrated robust CSFT control with a median time of 39 weeks ...
The EndoArt artificial endothelial layer showed positive results across multiple studies presented by specialists at the ...
New 52-week analyses from the phase 3 SOL-1 trial suggest that the investigational intravitreal therapy AXPAXLI (OTX-TKI) may ...
If rolled out this year, it would affect state pensioners born before 1956.
Patients who received the Tecnis PureSee extended depth of focus IOL had a high tolerance to residual refractive error, ...
New SOL-1 post-hoc analyses presented at VBS reinforce AXPAXLI’s unmatched durability in wet AMD with sustained disease controlAXPAXLI ...
Reproxalap was found to be safe to take in patients diagnosed with dry eye disease (DED), as no serious treatment-emergent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results